Answers are grounded in this paper and cite their sources.
Taken together, our findings suggest that exosomal TRIM3 may serve as a biomarker for gastric cancer diagnosis and the delivery of TRIM3 by exosomes may provide a new avenue for gastric cancer therapy.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: